{"id":11300,"date":"2022-07-01T20:31:38","date_gmt":"2022-07-02T00:31:38","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/critical-advances-in-immunotherapy-for-kidney-cancer\/"},"modified":"2022-07-14T16:03:01","modified_gmt":"2022-07-14T20:03:01","slug":"critical-advances-immunotherapy-for-kidney-cancer","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/critical-advances-immunotherapy-for-kidney-cancer","title":{"rendered":"Critical Advances in Immunotherapy for Kidney Cancer"},"content":{"rendered":"<p style=\"text-align: center;\"><text align:=\"\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/yAcnfuavQR0\" width=\"640\"><\/iframe><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><text><\/text><\/p>\n<p>On March 16, 2016, Nizar M. Tannir, MD, FACP,&nbsp; professor and deputy chair of the department of genitourinary medical oncology at The University of Texas MD Anderson Cancer Center, discussed the latest current immunotherapy treatment options for patients with kidney cancer, and how close we are to making these treatments available to more patients.&nbsp;<\/p>\n<p>Dr. Tannir has conducted numerous clinical trials in renal cell carcinoma (RCC), and is an expert on rare kidney cancers. Dr. Tannir has authored more than 150 original manuscripts and has received numerous awards, including the Gerald P. Bodey Award for Excellence in Education and the Melvin L. Samuels Award for Excellence in Patient Care.<\/p>\n<p>Cancer Research Institute&#39;s new webinar series, &quot;Cancer Immunotherapy and You,&quot; are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This series is presented by Genentech and LabAnswer and its employees, with generous support from Celldex Therapeutics and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\" target=\"_blank\" rel=\"noopener\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.&nbsp;<\/p>\n","protected":false},"featured_media":3497,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11300","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Critical Advances in Immunotherapy for Kidney Cancer<\/title>\n<meta name=\"description\" content=\"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Critical Advances in Immunotherapy for Kidney Cancer\" \/>\n<meta property=\"og:description\" content=\"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ea29e035-5df7-445a-93c4-afab4ff7c342.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Critical Advances in Immunotherapy for Kidney Cancer\" \/>\n<meta name=\"twitter:description\" content=\"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ea29e035-5df7-445a-93c4-afab4ff7c342.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer\",\"name\":\"Critical Advances in Immunotherapy for Kidney Cancer\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg\",\"datePublished\":\"2022-07-02T00:31:38+00:00\",\"dateModified\":\"2022-07-14T20:03:01+00:00\",\"description\":\"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Critical Advances in Immunotherapy for Kidney Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Critical Advances in Immunotherapy for Kidney Cancer","description":"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer","og_locale":"es_ES","og_type":"article","og_title":"Critical Advances in Immunotherapy for Kidney Cancer","og_description":"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0","og_url":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:03:01+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ea29e035-5df7-445a-93c4-afab4ff7c342.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Critical Advances in Immunotherapy for Kidney Cancer","twitter_description":"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ea29e035-5df7-445a-93c4-afab4ff7c342.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer","url":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer","name":"Critical Advances in Immunotherapy for Kidney Cancer","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg","datePublished":"2022-07-02T00:31:38+00:00","dateModified":"2022-07-14T20:03:01+00:00","description":"Dr. Nizar M. Tannir of MD Anderson discusses the latest advances in immunotherapy for patients with kidney cancer.\u00a0","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/936965a4-83d5-49c5-a471-9d9d173d9bea.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/critical-advances-immunotherapy-for-kidney-cancer#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Critical Advances in Immunotherapy for Kidney Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/3497"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11300"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11300"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11300"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11300"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11300"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11300"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}